Intestinal protein may have role in ADHD, other neurological disorders

August 11, 2011, Cincinnati Children's Hospital Medical Center

A biochemical pathway long associated with diarrhea and intestinal function may provide a new therapeutic target for treating ADHD (Attention Deficit Hyperactivity Disorder) other neuropsychiatric disorders, according to a team of scientists from China and the United States reporting Aug. 11 in Science.

Scientists have for the last quarter century studied the intestinal protein, guanylyl cyclase-C (GC-C) for its role in diarrheal disease and other intestinal functions, according to Mitchell Cohen, M.D., U.S. author on the study and director of Gastroenterology, Hepatology and Nutrition at Cincinnati Children's Hospital Medical Center. In fact, it had been thought that GC-C was found primarily in the intestine.

In the current study, scientists in China who collaborated with Dr. Cohen discovered that the receptor is also expressed in critical areas of the brain. The senior author on the study is Dr. Minmin Luo, a researcher at the National Institute of Biological Sciences and Tsinghua University in Beijing.

Using a mouse model developed in Dr. Ralph Giannella's laboratory at the University of Cincinnati, in which the GC-C receptor is deleted, or knocked out, the researchers found the mice exhibit hyperactivity and attention deficits. It is the first time that GC-C has been linked to , according to the researchers.

"We show that the neurons selectively express GC-C and that its activation amplifies the excitatory responses mediated by other receptors on dopamine neurons in the midbrain," said Dr. Luo. "Working through a protein kinase called PKG, GC-C activity increases brain dopamine levels and thus regulate mouse attention and activity level."

When the researchers treated the GC-C with amphetamine-based ADHD medication and a PKG activator, it reversed their hyperactive, inattentive behavior.

"The results indicate important behavioral and physiological functions for the GC-C/PKG signaling pathway in the brain," said Dr. Luo. "The data also suggest new therapeutic targets for neuropsychiatric disorders related to malfunctions of midbrain dopamine receptors."

One of the most prevalent human behavioral disorders, ADHD has been linked to imbalances in the dopamine system. The researchers noted in the study that its findings – mice exhibiting reduced dopamine levels and related behavioral problems – are consistent with the biochemical characteristics of human ADHD.

"This could make the GC-C knockout mouse a good research model for ADHD and other behavioral disorders," said Dr. Cohen. "Efforts to develop activators or inhibitors of the GC-C/PKG signaling pathway may lead to novel treatments for other disorders, such schizophrenia, Parkinson's disease and addiction."

Related Stories

Recommended for you

Global study finds youngest in class more likely to be diagnosed with ADHD

October 15, 2018
A new global study involving the University of Adelaide has found that children who are the youngest in their classroom are more likely to be diagnosed with Attention Deficit Hyperactivity Disorder (ADHD) than their older ...

Much still unclear about relationship between screen media use and ADHD in children

October 5, 2018
There is a statistically small relationship between children's screen media use and ADHD-related behaviours. This is the finding of an extensive literature review on this subject carried out by researchers from the UvA's ...

Brain scans reveal common patterns can predict variations in ADHD

September 24, 2018
Distinct brain patterns can help explain variations in the way children present with attention deficit hyperactivity disorder (ADHD), paving a course towards improved treatment and support for the common neurodevelopmental ...

ADHD may increase risk of Parkinson's disease and similar disorders

September 12, 2018
While about 11 percent of children (4-17 years old) nationwide have been diagnosed with attention-deficit hyperactivity disorder (ADHD), the long-term health effects of having ADHD and of common ADHD medications remains understudied. ...

Over past 20 years, percentage of children with ADHD nearly doubles

September 3, 2018
The number of children diagnosed with attention deficit hyperactivity disorder has reached more than 10 percent, a significant increase during the past 20 years, according to a study released Friday.

ADHD rates rising sharply in US kids

August 31, 2018
(HealthDay)—The number of ADHD diagnoses among children has risen dramatically in the past two decades, going from 6 percent to 10 percent, a new report shows.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.